Purchase Order 36C26122P1694

<p>The National Institutes of Health, through the Office of Logistics and Acquisition Operations, awarded a purchase order to Genecopoeia, Inc. for $11,000.00 on August 22, 2014, for generation of a transgenic mouse line containing 3'&amp;5'-terminal EGFP tag. Genecopoeia is a minority-owned, Asian-Pacific American-owned biotechnology firm. Place of performance is Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of January 5, 2019.</p>

This federal contract award to Ozgene PTY LTD, an Australian company, is for the delivery of genetically modified mice and related services to support biomedical research at various institutes and centers within the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The specific services provided under this $5,970.00 firm fixed price delivery order contract include gene targeting vector design and creation, mouse embryonic stem cell generation, blastocyst...

This federal contract award to Ozgene PTY LTD, an Australian company, is for the provision of genetically modified mice and related services to support biomedical research. The $2,024 firm fixed-price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. Ozgene, the prime contractor, will deliver gene targeting vectors, mouse backcrossing, and the creation...

This federal contract award to Ozgene Pty Ltd, an Australian company, provides genetically modified mice and related services to support biomedical research for the National Institutes of Health (NIH). The $7,286 firm fixed-price contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), is for the delivery of &quot;Live Animals, Not Raised for Food&quot; and has an ultimate completion date of April 28, 2010. Ozgene, as the prime contractor, provides gene targeting...

<p>The National Institute of Child Health and Human Development issued a purchase order to Cyagen US Inc. for $97,577 on September 14, 2020, for turboknockout mouse gene targeting services. Work is performed in Santa Clara, California. The order is firm fixed price with an ultimate completion date of June 22, 2021. The underlying solicitation was posted August 12, 2020, with a due date of August 21, 2020.</p>

This firm-fixed-price purchase order contract, valued at $13,594.30, was awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Cyagen Biomodels LLC, a for-profit biotechnology company located in Santa Clara, California. The contract is for the generation of a TBX3 conditional knockout mouse strain to support biomedical research. No small business set-aside was used for this award. Cyagen Biomodels LLC specializes in...

This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The $148,900.00 contract is for the provision of other functions including the creation of genetically modified knockout and...

The federal contract award is to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The award was made by the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Child Health and Human Development (NICHD), to deliver gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice. The...

The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $121,347 firm fixed price purchase order to Cyagen Biomodels LLC of Santa Clara, California. The contract is for the generation of conditional knock-in and knock-out mouse models to support the agency's research focusing on the development of the mammalian hematopoietic system and study of signal transduction molecules and pathways that regulate T...

The U.S. Department of Defense's Medical Command awarded a Firm Fixed Price Purchase Order contract valued at $129,064.01 to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, identified as W81XWH16P0294, is for the MIR-188 GENE TARGETING effort, which was set aside for small businesses. The period of performance runs through October 30, 2020. Based on the information provided, Ozgene serves as the...